Aequus Pharmaceuticals Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Public

  • Employees
  • 18

Employees

  • Stock Symbol
  • AQS

Stock Symbol

  • Investments
  • 3

Aequus Pharmaceuticals General Information

Description

Aequus Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The firm's operating segments are the Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. The company earns revenues from the sale of dry eye products and by providing promotional services to sell third-party-owned products namely Tacrolimus IR and Vistitan.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 200 Granville Street
  • Suite 2820
  • Vancouver, British Columbia V6C 1S4
  • Canada
+1 (604)
Primary Industry
Pharmaceuticals
Other Industries
Drug Delivery
Stock Exchange
TSX
Vertical(s)
Corporate Office
  • 200 Granville Street
  • Suite 2820
  • Vancouver, British Columbia V6C 1S4
  • Canada
+1 (604)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aequus Pharmaceuticals Stock Performance

As of 25-Apr-2025, Aequus Pharmaceuticals’s current market cap is $478K with 133M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$478K 133M 164K -$0.01

Aequus Pharmaceuticals Financials Summary

As of 30-Sep-2025, Aequus Pharmaceuticals has a trailing 12-month revenue of $656K.

In Thousands,
USD
TTM 30-Sep-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022
EV 5,463 5,510 4,950
Revenue 656 426 189 1,059
EBITDA (159) (1,310) (1,989) (2,219)
Net Income (469) (1,588) (2,195) (2,464)
Total Assets 141 558 819 1,246
Total Debt 4,332 4,607 3,817 2,050
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Aequus Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Aequus Pharmaceuticals‘s full profile, request access.

Request a free trial

Aequus Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Aequus Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The firm's operating segments are the Com
Pharmaceuticals
Vancouver, Canada
18 As of 2025

Dublin, Ireland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aequus Pharmaceuticals Competitors (1)

One of Aequus Pharmaceuticals’s competitors is Perrigo Company, a Corporation company based in Dublin, Ireland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Perrigo Company Corporation Dublin, Ireland
You’re viewing 1 of 1 competitors. Get the full list »

Aequus Pharmaceuticals Patents

Aequus Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2017029567-A1 Transdermal and/or topical delivery system comprising clobazam Inactive 17-Aug-2015
CA-2995431-A1 Transdermal delivery of doxylamine succinate and pyridoxine hydrochloride Inactive 17-Aug-2015
EP-3337480-A1 Transdermal delivery of doxylamine succinate and pyridoxine hydrochloride Inactive 17-Aug-2015
EP-3337480-A4 Transdermal delivery of doxylamine succinate and pyridoxine hydrochloride Inactive 17-Aug-2015
US-20180250281-A1 Transdermal delivery of doxylamine succinate and pyridoxine hydrochloride Inactive 17-Aug-2015 A61K31/4415
To view Aequus Pharmaceuticals’s complete patent history, request access »

Aequus Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aequus Pharmaceuticals Investments & Acquisitions (3)

Aequus Pharmaceuticals’s most recent deal was a Joint Venture with Joint Venture (Aequus Pharmaceuticals / Medicom). The deal was made on 22-Sep-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Joint Venture (Aequus Pharmaceuticals / Medicom) 22-Sep-2020 Joint Venture Other Devices and Supplies
Cannabis-based Therapies (CannaRoyalty / Aequus Pharmaceuticals) 11-Jan-2018 Joint Venture Biotechnology
TeOra Health 28-Jul-2015 Merger/Acquisition Pharmaceuticals
To view Aequus Pharmaceuticals’s complete investments and acquisitions history, request access »

Aequus Pharmaceuticals ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Aequus Pharmaceuticals’s complete esg history, request access »

Aequus Pharmaceuticals FAQs

  • When was Aequus Pharmaceuticals founded?

    Aequus Pharmaceuticals was founded in 2013.

  • Where is Aequus Pharmaceuticals headquartered?

    Aequus Pharmaceuticals is headquartered in Vancouver, Canada.

  • What is the size of Aequus Pharmaceuticals?

    Aequus Pharmaceuticals has 18 total employees.

  • What industry is Aequus Pharmaceuticals in?

    Aequus Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Aequus Pharmaceuticals a private or public company?

    Aequus Pharmaceuticals is a Public company.

  • What is Aequus Pharmaceuticals’s stock symbol?

    The ticker symbol for Aequus Pharmaceuticals is AQS.

  • What is the current market cap of Aequus Pharmaceuticals?

    The current market capitalization of Aequus Pharmaceuticals is $478K.

  • What is Aequus Pharmaceuticals’s current revenue?

    The trailing twelve month revenue for Aequus Pharmaceuticals is $656K.

  • Who are Aequus Pharmaceuticals’s competitors?

    Perrigo Company is a competitor of Aequus Pharmaceuticals.

  • What is Aequus Pharmaceuticals’s annual earnings per share (EPS)?

    Aequus Pharmaceuticals’s EPS for 12 months was -$0.01.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process